Table 6. Angiotensin-converting enzyme inhibition activity of MV1)
Dilution rate | Angiotensin-converting enzyme inhibition activity (%) |
Fermentation time (day) |
0 | 9 |
100 | 16.71±1.912) | 21.63±0.93*3) |
50 | 30.10±1.46 | 37.24±1.38** |
25 | 44.82±0.26 | 63.88±1.23*** |
5 | 80.72±1.08 | 86.46±0.97** |
Captopril4) | IC50: 49.10±0.27 ng/mL |
Mulberry vinegar through yeast and acetic acid bacteria fermentation.
Values are mean±SD (n=3).
Significant differences were compared with the ‘before fermentation’ at *p<0.05, **p<0.01 and ***p<0.001 in the same row by Levene’s t-test.
Positive control in assay (captopril IC50: 49.10±0.27 ng/mL).